Fig. 4From: Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapyKaplan-Meier plots showing the incidence of PSA progression-free survival rate classified by D’Amico risk groupingBack to article page